Editor

8390 POSTS
0 COMMENTS

Breast Most cancers Prognosis: What Are Its Objectives And Advantages? – TheHealthSite

Breast Most cancers Prognosis: What Are Its Objectives And Advantages?  TheHealthSite

EGFR Non-Small Cell Lung Most cancers Scientific Trial Pipeline

New York, USA, July 03, 2024 (GLOBE NEWSWIRE) -- EGFR Non-Small Cell Lung Most cancers Scientific Trial Pipeline Seems Strong With...

FDA Grants Quick Monitor Designation to 225Ac-FL-020 for mCRPC

The FDA has granted quick monitor designation to the prostate-specific membrane antigen (PSMA)–focused radiopharmaceutical 225Ac-FL-020 for the therapy of sufferers with metastatic castration-resistant...

Elacestrant + Focused Remedy for ER+/HER2– Metastatic Breast Most cancers: Early Section Trial Findings

The ELEVATE trial (NCT05563220) is an ongoing part 1b/2 examine investigating elacestrant (Oserdu) mixed with numerous focused therapies for sufferers with endocrine rececptor-positive...

Editor

8390 POSTS
0 COMMENTS
spot_img